CompletedNot Applicable

Parental Cognitions and Children's Wellbeing

United Kingdom90 participantsStarted 2021-10-31

Plain-language summary

The current study aims to address the research limitations in previous studies by adopting a longitudinal design to investigate the associations between parental cognitions (parental expectations, parental beliefs, and parental attributional styles) and adolescents' wellbeing, resilience, and coping strategies across an extended period. Two main research questions were posed: 1) What are the associations between parental cognition factors (parental attribution, parental expectations, and parental beliefs and adolescents' outcomes (wellbeing, resilience, and stress-coping)? 2) Which parental cognition factor has the highest probability in predicting the changes of adolescents' wellbeing, resilience, and coping strategies over time? To answer these research questions, bayesian regression analysis was used to identify the best fitting model of adolescents' wellbeing outcomes and to discern the risk and protective roles of parental cognition factors within the model. Bayesian regression approach also enables the assignment of probabilities to each parental cognition factor, quantifying their credibly in relation to adolescents' wellbeing outcomes.

Who can participate

Age range

11 Years – 16 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Criteria for participation were parents and their adolescents aged 11 to 16 years old who have no neurodevelopmental conditions reported by parents (specifically to developmental disorders that may include learning difficulties, such as ASD, ADHD, and intellectual disability). Exclusion Criteria: * Adolescents with neurodevelopmental disorders, adolescents aged younger than 11 years old or older than 16 years old, and adolescents and parents who are not fluent in English will also be excluded as the measurements in this study are written in English.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Wellbeing

Timeframe: 6 months

Resilience

Timeframe: 6 months

Coping Styles

Timeframe: 6 months

Trial details

NCT IDNCT06159738

SponsorUniversity of Edinburgh

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-11-15

View on ClinicalTrials.gov More Adolescent Development trials

Plain-language summary

Who can participate

Age range

11 Years – 16 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.